Cancer comes from your own cells. It begins when a normal cell accumulates enough damage to its DNA that it starts growing and dividing without the usual controls. This isn’t a single event but a process that unfolds over years or decades, which is why the median age of a cancer diagnosis is 67. The damage can come from several sources: random copying errors when cells divide, environmental exposures like tobacco smoke or UV radiation, infections, inherited genetic flaws, or some combination of all of these.
How a Normal Cell Becomes Cancerous
Your body contains trillions of cells, and they divide constantly to replace old or damaged tissue. Every time a cell divides, it copies its entire DNA, and that copying process isn’t perfect. Mistakes slip in. Most of the time, built-in repair systems catch and fix these errors, or the cell is instructed to self-destruct through a process called programmed cell death. Cancer develops when these safety systems break down.
Three types of genes play central roles. Proto-oncogenes are normal genes that tell cells when to grow and divide. They work like an accelerator pedal, and they’re usually switched off when not needed. If a mutation flips a proto-oncogene permanently on, it becomes an oncogene, pressing the accelerator nonstop and driving uncontrolled growth. Tumor suppressor genes do the opposite: they slow cell division, repair DNA mistakes, and trigger cell death when damage is too severe. When these genes get knocked out by mutations, the brakes fail. A well-known example is the TP53 gene, which normally forces cells with damaged DNA to stop dividing or die. When TP53 is mutated, cells with broken DNA keep multiplying.
A single mutation usually isn’t enough. Cancer typically requires multiple mutations accumulating in the same cell lineage, hitting both accelerators and brakes, before a tumor forms. This is why cancer takes time to develop and why risk climbs with age.
Why Age Is the Biggest Risk Factor
Cancer incidence rises steeply as people get older. In age groups under 20, there are fewer than 26 cases per 100,000 people. By ages 45 to 49, that number reaches about 350 per 100,000. Past age 60, it exceeds 1,000 per 100,000. The National Cancer Institute calls advancing age the single most important risk factor for cancer overall.
The reason is straightforward: the longer your cells have been dividing, the more opportunities there are for mutations to accumulate. Each decade of life adds more copying errors, more exposure to environmental damage, and more chances for the repair systems themselves to become compromised. By the time enough mutations stack up in the right combination, a cell line can escape normal growth controls entirely.
The “Bad Luck” Factor
A significant share of cancer-driving mutations come not from anything you did or were exposed to, but from random errors during routine cell division. Mathematical models have shown that the lifetime risk of several common cancers, including colon, breast, prostate, pancreatic, and thyroid cancers, can be largely explained by the sheer number of stem cell divisions that occur over a lifetime. Tissues where stem cells divide more frequently tend to have higher cancer rates, independent of environmental exposures.
This doesn’t mean lifestyle doesn’t matter. It means that even in a perfectly clean environment, cancer would still exist because DNA replication is inherently imperfect. Random replication errors and environmental factors work together: the more mutations you start with from copying errors, the fewer additional hits from carcinogens it takes to push a cell over the edge.
Lifestyle and Environmental Causes
Only about 5 to 10 percent of all cancers trace back to inherited genetic defects. The remaining 90 to 95 percent have roots in environment and lifestyle. The breakdown of cancer-related deaths in the United States tells a striking story: tobacco accounts for roughly 25 to 30 percent, diet contributes 30 to 35 percent, infections cause 15 to 20 percent, and obesity adds another 10 to 20 percent. Combined, tobacco and diet alone are linked to 60 to 70 percent of cancer deaths worldwide.
The International Agency for Research on Cancer has classified 135 substances and exposures as definitive human carcinogens (Group 1). These include tobacco smoke, alcohol, processed meat, UV radiation, asbestos, and certain industrial chemicals. Each of these works by damaging DNA in ways that accumulate over time, increasing the odds that the critical combination of mutations will eventually occur in a cell.
Physical inactivity also plays a role. It has been linked to higher rates of breast, colon, prostate, and pancreatic cancers. People with the highest levels of physical activity show roughly a 50 percent reduction in colon cancer incidence compared to the least active groups. Excess body weight contributes to an estimated 14 percent of cancer deaths in men and 20 percent in women in the United States.
Infections That Cause Cancer
About 2.2 million cancer cases per year worldwide are caused by infectious agents. The bacterium H. pylori is the single largest contributor, responsible for roughly 850,000 infection-related cancers annually (36 percent of the total), primarily stomach cancer. High-risk strains of human papillomavirus (HPV) cause about 730,000 cases (31 percent), including cervical, anal, and head and neck cancers. Hepatitis B accounts for around 380,000 cases (16 percent) and hepatitis C for about 170,000 (7 percent), both primarily causing liver cancer.
Other confirmed cancer-causing pathogens include Epstein-Barr virus (linked to certain lymphomas and nasopharyngeal cancer), human T-cell lymphotropic virus type 1, and Kaposi sarcoma-associated herpesvirus. Even certain parasites, including liver flukes found in parts of Southeast Asia, are classified as definitive human carcinogens. These organisms cause cancer through various mechanisms: some trigger chronic inflammation that damages DNA over years, others insert their own genetic material into host cells in ways that disrupt growth controls.
Inherited Cancer Risk
About 5 to 10 percent of cancers result from genetic mutations you’re born with. These are called germline mutations because they exist in every cell of your body from conception. The most widely known examples are BRCA1 and BRCA2 mutations, which substantially increase the risk of breast and ovarian cancers, but inherited mutations in dozens of other genes can raise risk for colorectal, prostate, pancreatic, and other cancers.
Having an inherited mutation doesn’t guarantee cancer. It means you start life with one of the required “hits” already in place, so fewer additional mutations are needed for a cell to become cancerous. This is why hereditary cancers tend to appear at younger ages than sporadic ones. If multiple close relatives on one side of your family developed the same type of cancer, especially before age 50, that pattern may point to an inherited component.
Changes Beyond the DNA Sequence
Not all cancer-driving changes involve mutations in the DNA code itself. Epigenetic modifications, chemical tags that sit on top of DNA and its packaging proteins, control which genes are active and which are silent. These tags can be added or removed by enzymes, and when the system goes wrong, tumor suppressor genes can get silenced or oncogenes can get activated without any change to the underlying genetic sequence.
Two of the most important epigenetic mechanisms in cancer are DNA methylation (adding chemical groups directly to DNA that shut genes down) and histone modification (altering the proteins that DNA wraps around, which changes how tightly packed and accessible certain genes are). An imbalance in these processes can push cells toward uncontrolled growth, increased ability to spread, and resistance to cell death. This layer of regulation helps explain why genetically identical cells can behave very differently and why environmental factors like diet and chemical exposures can influence cancer risk without directly mutating DNA.
How the Immune System Normally Stops Cancer
Your immune system catches and destroys abnormal cells constantly. This process, called immune surveillance, works through multiple layers. Natural killer cells patrol the body and can detect when a cell’s surface markers look abnormal due to transformation. They carry both activating and inhibiting receptors: healthy cells display molecules that trigger the “don’t attack” signal, but transformed cells often lose those molecules, giving natural killer cells the green light.
T cells provide a second layer of defense. When cancer cells accumulate mutations, they produce abnormal proteins that the immune system has never seen before. These new proteins, called neoantigens, get flagged and presented to T cells, which can then target and kill the cancer cells specifically. This system works well enough that most precancerous cells never become tumors.
Cancer that does develop has, by definition, found ways around this surveillance. Tumor cells can create a local environment that suppresses immune activity, essentially building a shield around themselves. They can also exhaust the T cells sent to fight them through prolonged exposure, gradually wearing down the immune response until the T cells lose their ability to kill effectively. This exhaustion process, where T cells become progressively less functional after chronic activation, is one of the key reasons established tumors are so difficult for the body to eliminate on its own.